CN1293988A - Chinese medicine 'Shexianfengshi wan' - Google Patents
Chinese medicine 'Shexianfengshi wan' Download PDFInfo
- Publication number
- CN1293988A CN1293988A CN99114523A CN99114523A CN1293988A CN 1293988 A CN1293988 A CN 1293988A CN 99114523 A CN99114523 A CN 99114523A CN 99114523 A CN99114523 A CN 99114523A CN 1293988 A CN1293988 A CN 1293988A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- radix
- chinese medicine
- radix angelicae
- shexianfengshi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A Chinese medicine in the form of pills for treating rheumatic arthritis, rheumatoid arthritis, periomethritis, ischias, etc is prepared from 15 Chinese-medicinal materials including clematis root, notopterygium root, pubescent angelica root, Chinese angelica root, etc. Its advantages include high curative effect and safety (effective rate up to 97%).
Description
The present invention relates to Chinese medicine.More particularly, be a kind of Chinese medicine that is used for the treatment of rheumatic joint disease.
Rheumatism is one of commonly encountered diseases, is again a kind of pertinacious disease in the common clinical, how by wind-cold damp pathogen invade meridians, numbness resistance obstructed due to.Patient's joint numbness pain, more so overcast and rainy, can not get into bed the severe patient difficulty in walking normal night.Though the rheumatismal Chinese medicine and western medicine of existing treatment is a lot.But Western medicine mostly is hormone drugs, use always and diminish gastrointestinal, and internal organs, side effect is big, is difficult to radical cure; Chinese medicine again more adopts Scorpio class medical materials such as Radix Aconiti, Radix Aconiti Kusnezoffii, Scolopendra, and this class medical material all has certain toxic and side effects.
The objective of the invention is to avoid weak point of the prior art, provide a kind of safe, efficient, treatment cycle short, cheap be used for the treatment of various rheumatismal 'Shexianfengshi wan ' Chinese medicines.
Purpose of the present invention is achieved through the following technical solutions.
The present invention is made up of the following Chinese medicine of respectively distinguishing the flavor of:
Agkistrodon, Zaocys, Radix Clematidis, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Radix Angelicae Sinensis, Fructus Chaenomelis, Rhizoma Atractylodis, Rhizoma Homalomenae, Radix Notoginseng, the Cortex Eucommiae, Rhizoma Cibotii, Semen Sinapis Albae, Caulis Spatholobi, Mel.
The above-mentioned Chinese medicine of respectively distinguishing the flavor of is by following weight ratio prescription:
Agkistrodon 20-40g, Zaocys 47-93g, Radix Clematidis 47-93g, Rhizoma Et Radix Notopterygii 27-53g,
Radix Angelicae Pubescentis 27-53g
Radix Angelicae Sinensis 47-93g, Fructus Chaenomelis 33-67g, Rhizoma Atractylodis 33-67g, Rhizoma Homalomenae 47-93g,
Radix Notoginseng 13-27g
Cortex Eucommiae 20-40g, Rhizoma Cibotii 47-93g, Semen Sinapis Albae 27-53g, Caulis Spatholobi 113-227g,
Mel 270-530g.
In the above-mentioned prescription of the present invention, Agkistrodon, expel wind to dredge collateral; Zaocys heightens the effect of a treatment; Radix Clematidis, wind-damp dispelling pain relieving, the meridian dredging; Rhizoma Et Radix Notopterygii, the rheumatalgia above the waist of dispelling; Radix Angelicae Pubescentis, the lower part of the body rheumatalgia of dispelling; Radix Angelicae Sinensis, blood circulation promoting and enriching; Fructus Chaenomelis, relaxing muscles and tendons and activating QI and blood in the collateral, detumescence; Rhizoma Atractylodis are drying damp and strengthening spleen; Rhizoma Homalomenae, wind-damp dispelling, strengthening bone and muscle, numbness disappears; Radix Notoginseng, dissipating blood stasis for subsidence of swelling, analgesic therapy; The Cortex Eucommiae, invigorating the liver and kidney, bone and muscle strengthening; Rhizoma Cibotii, invigorating the liver and kidney, wind-damp dispelling, sweet temperature is supporing yang; Semen Sinapis Albae, warming for resolving cold-phlegm, mass dissipating and swelling eliminating; Caulis Spatholobi, blood circulation promoting and blood stasis dispelling, dredge the meridian passage; Mel, sweet flat nourishing YIN.
The present invention cures mainly function: expelling wind and removing dampness, expel wind to dredge collateral, blood circulation promoting and blood stasis dispelling, dispersing cold for relieving pain, reinforcement and elimination in combination.Be applicable to the rheumarthrosis due to wind, cold, damp, expectorant, the stasis of blood, the void.Cure mainly diseases such as rheumatic arthritis, rheumatoid arthritis, scapulohumeral periarthritis, sciatica, lumbago and skelalgia, numb hand and foot.
Through clinical practice data record, to case summary surplus 700, recovery from illness accounts for 87%, takes a turn for the better and accounts for 10%, invalidly accounts for 3%, and total effective rate is 97%.
Preparation method of the present invention:
A, choose and state each high-quality Chinese crude drug, roguing is cleaned standby.
B, except that Mel, all the other Chinese crude drug steam steaming and decoctings of respectively distinguishing the flavor of, to Shanghai Automobile Factory for the degree.
C, dry or dry after, pulverize, fineness is 120 orders.
D, adding Mel are used the machine pelleting behind the mixing, every ball weighs 9 grams.
The present invention has following advantage:
1, the present invention is a pure Chinese medicinal preparation, have no side effect, and reinforcement and elimination in combination, evident in efficacy.
2, the present invention does not have rare medicinal herbs, and cost is low, can alleviate patient's financial burden.
3, treatment cycle is short, 7 days one courses of treatment, treating both the principal and secondary aspects of a disease.
4, crude drug source of the present invention is extensive, is the conventional Chinese medicine material.
By the following examples the present invention is further described.
Embodiment 1
Present embodiment is filled a prescription by following weight ratio:
Agkistrodon 20g, Zaocys 47g, Radix Clematidis 47g, Rhizoma Et Radix Notopterygii 27g, Radix Angelicae Pubescentis 27g
Radix Angelicae Sinensis 47g, Fructus Chaenomelis 33g, Rhizoma Atractylodis 33g, Rhizoma Homalomenae 47g, Radix Notoginseng 13g
Cortex Eucommiae 20g, Rhizoma Cibotii 47g, Semen Sinapis Albae 27g, Caulis Spatholobi 113g, Mel 270g.
Preparation method:
The Chinese crude drug high-quality person that respectively distinguishes the flavor of in A, the apolegamy side, roguing is cleaned standby.
B, except that Mel, each Chinese crude drug of distinguishing the flavor of steam steaming and decocting, to Shanghai Automobile Factory for the degree.
Chinese crude drug after C, the steaming and decocting is after drying or drying, and pulverizing, fineness are 120 orders.
D, Mel is added the fine powder mixing, use the machine pelleting, every ball weighs 9 grams.
Using method:
Take secondary every day, clothes are obeyed the 2-4 ball at every turn sooner or later.
Taboo: raw food and seat wetland for sleeping in.Hot arthritis and the careful usefulness of flu patient.
Embodiment 2
Present embodiment is filled a prescription by following weight ratio:
Agkistrodon 30g, Zaocys 70g, Radix Clematidis 70g, Rhizoma Et Radix Notopterygii 40g, Radix Angelicae Pubescentis 40g,
Radix Angelicae Sinensis 70g, Fructus Chaenomelis 50g, Rhizoma Atractylodis 50g, Rhizoma Homalomenae 70g, Radix Notoginseng 20g,
Cortex Eucommiae 30g, Rhizoma Cibotii 70g, Semen Sinapis Albae 40g, Caulis Spatholobi 170g, Mel 400g.
All the other are with embodiment 1.
Embodiment 3
Present embodiment is filled a prescription by following weight ratio:
Agkistrodon 40g, Zaocys 93g, Radix Clematidis 93g, Rhizoma Et Radix Notopterygii 53g, Radix Angelicae Pubescentis 53g,
Radix Angelicae Sinensis 93g, Fructus Chaenomelis 67g, Rhizoma Atractylodis 67g, Rhizoma Homalomenae 93g, Radix Notoginseng 27g,
Cortex Eucommiae 40g, Rhizoma Cibotii 93g, Semen Sinapis Albae 53g, Caulis Spatholobi 227g, Mel 530g.
All the other are with embodiment 1.
Case 1
Poplar, the man, 47 years old, the workman, in the colliery underground work, two knee joints and both shoulders arthralgia are diagnosed as chronic rheumatic arthritis because of for a long time.Reach 10 years, cure and do not heal, have no alternative but early retirement.Come to seek medical advice in February, 1996, cure, recovery from illness in 7 months through the present invention.
Case 2
Zhang, the woman, 48 years old, at an early age, to work in the paddy field, do not set up puerperal again.Before 4 years, lumbago, pain in foot, hospital diagnosis is a sciatica.Though all do not cure through several families hospital treatment.Come to go to a doctor in July, 1994, through the present invention's treatment, and recovery from illness in 2 months.
Case 3
Bai, man, 57 years old, the secretary of factory.Before 7 years, two limb arthralgia, shoulder joint wins especially, praises difficulty, obstinate.Come to seek medical advice in April, 1994, is diagnosed as scapulohumeral periarthritis, cures recovery from illness in 4 months through the present invention.
Claims (2)
1, a kind of 'Shexianfengshi wan ' Chinese medicine that is used for the treatment of rheumatic joint disease is characterized in that being made of the following Chinese crude drug of respectively distinguishing the flavor of:
Agkistrodon, Zaocys, Radix Clematidis, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Radix Angelicae Sinensis, Fructus Chaenomelis, Rhizoma Atractylodis, Rhizoma Homalomenae, Radix Notoginseng, the Cortex Eucommiae, Rhizoma Cibotii, Semen Sinapis Albae, Caulis Spatholobi, Mel.
2,, it is characterized in that the described Chinese crude drug of respectively distinguishing the flavor of is by following weight ratio prescription according to the right 1 described 'Shexianfengshi wan ' Chinese medicine that is used for the treatment of rheumatic joint disease:
Agkistrodon 20-40g, Zaocys 47-93g, Radix Clematidis 47-93g, Rhizoma Et Radix Notopterygii 27-53g, Radix Angelicae Pubescentis 27-53g
Radix Angelicae Sinensis 47-93g, Fructus Chaenomelis 33-67g, Rhizoma Atractylodis 33-67g, Rhizoma Homalomenae 47-93g, Radix Notoginseng 13-27g
Cortex Eucommiae 20-40g, Rhizoma Cibotii 47-93g, Semen Sinapis Albae 27-53g, Caulis Spatholobi 113-227g, Mel 270-530g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99114523A CN1130220C (en) | 1999-10-30 | 1999-10-30 | Chinese medicine 'Shexianfengshi wan' |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99114523A CN1130220C (en) | 1999-10-30 | 1999-10-30 | Chinese medicine 'Shexianfengshi wan' |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1293988A true CN1293988A (en) | 2001-05-09 |
| CN1130220C CN1130220C (en) | 2003-12-10 |
Family
ID=5277596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99114523A Expired - Fee Related CN1130220C (en) | 1999-10-30 | 1999-10-30 | Chinese medicine 'Shexianfengshi wan' |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1130220C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1945234A4 (en) * | 2005-09-23 | 2010-04-21 | Kwangju Inst Sci & Tech | Composition for preventing or treating artritis comprising lactic acid bacteria and collangen as active ingredients |
-
1999
- 1999-10-30 CN CN99114523A patent/CN1130220C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1945234A4 (en) * | 2005-09-23 | 2010-04-21 | Kwangju Inst Sci & Tech | Composition for preventing or treating artritis comprising lactic acid bacteria and collangen as active ingredients |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1130220C (en) | 2003-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1229658A (en) | Compound sanbi medicinal liquor for treating gout | |
| CN1446558A (en) | Blaster for treating rheumatoid arthritis | |
| CN1857541A (en) | Plaster for treating rheumatism and osteoarthrosis | |
| CN1861187A (en) | Medicated wine for treating rheumatosis and osteoarthropathy | |
| CN1091609C (en) | Tincture for treating rheumatoid arthritis and its preparing process | |
| CN100450535C (en) | Chinese medicine for treating lumhardisc protrusion | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN1060391C (en) | Traditional Chinese medicine for treating gynecological tumour | |
| CN1739700A (en) | Rheumatism treating plaster and its prepn | |
| CN1117582C (en) | medicine for treating rheumatoid arthritis and preparing process thereof | |
| CN1876122A (en) | Medicinal ointment for treating hyperosteogeny, wind-cold-damp Bi, strain and sprain and preparation method thereof | |
| CN1843421A (en) | Rheumatoid disease treating medicine | |
| CN1317315A (en) | Tendon-comfortable analgesic | |
| CN1130220C (en) | Chinese medicine 'Shexianfengshi wan' | |
| CN101167864A (en) | Traditional Chinese medicinal formula for treating hyperosteogeny | |
| CN114652674A (en) | Blood circulation promoting and pain relieving ointment and preparation method thereof | |
| CN1063338C (en) | Traditional Chinese medicine preparation for curing cervical and lumbar hyperosteogeny | |
| CN103169876B (en) | Chinese medicament composition for treating arthralgia | |
| CN1141114C (en) | Tendon-conditioning analgetic | |
| CN1377672A (en) | Rheumatic pain killing preparation | |
| CN1695697A (en) | Medication for treating ache of rheumatoid arthritis | |
| CN1219402A (en) | Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method | |
| CN102743531B (en) | Drug for treating cervical or lumbar diseases and preparation method thereof | |
| CN102872293A (en) | Traditional Chinese medicinal powder for treating rheumatism and rheumatoid disease | |
| CN1891281A (en) | Chinese medicine preparation for treating wind-cold disease, and its preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Publication of application | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |